Interpace Biosciences (IDXG) Stock Highlights

2.84 | +6.77%

2024-12-21 07:38:00

Interpace Biosciences Inc is engaged in the life sciences industry. It provides complex molecular analysis for the early diagnosis and treatment of cancer and supporting the development of targeted therapeutics. It operates under one segment which is the business of developing and selling diagnostic clinical and pharma services.

Statistics

Range Today

2.6 2.86

Volume Today 5.5K

Range 1 Year

0.78 3.54

Volume 1 Year 1.81M

Range 3 Year

0.51 9

Volume 3 Year 5.51M

Range 10 Year

0.51 274

Volume 10 Year 190.82M

Highlights

Market Capitalization 12.51M (micro)

Floating Shares 3.36M

Current Price 2.84

Price To Earnings 2.51

Price To Revenue 0.23

Earnings Per Share 1.1

Payout Ratio 0%

Performance

Latest +6.77%

1 Month +8.81%

3 Months +79.75%

6 Months +134.71%

1 Year +178.43%

3 Years -64.28%

5 Years -40.83%

10 Years -98.24%

Benchmarks

Market Capitalization

57 / 58

Gross Profits

45 / 52

Total Revenue

45 / 57

Total Rank

17 / 58

Free Cashflow

28 / 56

Performance 5 years

33 / 58

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.